News

You are here:

Home
News

One Year Anniversary of Canada’s Cannabis Adult-Use Legalization: Illicit Consumption to Decline to 14% of Total Market By 2024

October 17, 2019

WASHINGTON–(BUSINESS WIRE)–New Frontier Data, the authority in data, analytics and business intelligence for the global cannabis industry, releases The Canada Cannabis Report: 2019 Industry Outlook. The report examines the Canadian cannabis market, including sales, consumer preferences, investments, jobs and more, following one year of federally legalized adult-use. The report also details future trends as retailers…

Details

Poxel Announces Participation at the H.C. Wainwright 3rd Annual NASH Investor Conference

October 17, 2019

LYON, France–(BUSINESS WIRE)–POXEL S.A. (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), announced today that it will be featured as a presenting company at the H.C. Wainwright 3rd Annual NASH Investor Conference and the Company will provide…

Details

Columbia Care Expands Dispensary Footprint, Announcing Openings in Maryland, Delaware and Florida

October 17, 2019

NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, today announced the addition of four new dispensaries with openings in Maryland, Delaware and Florida. Columbia Care’s facility in…

Details

Western USA CBD Regulatory Snapshot 2019: Focus on Nevada, Utah and Colorado – ResearchAndMarkets.com

October 17, 2019

DUBLIN–(BUSINESS WIRE)–The “Western USA: CBD Regulatory Snapshots” report has been added to ResearchAndMarkets.com’s offering. Discover the legal analysis of western US states Nevada, Utah and Colorado with this package of regulatory snapshots. Data includes legislations covering cultivation, THC, limits, import/export, permits, processing, vaping and hemp. This package will enable you to understand the regulatory landscape…

Details

2019 Toxicity and Notifications: Two-Part Guide To European CLP Regulations – ResearchAndMarkets.com

October 17, 2019

DUBLIN–(BUSINESS WIRE)–The “Toxicity and Notifications: A Two-Part Guide To European CLP Regulations” report has been added to ResearchAndMarkets.com’s offering. In Europe, all chemical substances and mixtures are now classified according to their toxicity levels, and it is necessary that these products are assessed by the industry before being placed on the market. Those that are…

Details

DionyMed Receives Notice of Default and Demand for Payment and Notice of Intention to Enforce Security

October 17, 2019

TORONTO–(BUSINESS WIRE)–DionyMed Brands Inc. (“DionyMed” or the “Company“) (CSE: DYME; OTCQB: DYMEF), a multi-state cannabis brands, direct-to-consumer and distribution platform, announced today that GLAS USA LLC (“GLAS USA”) , as administrative agent and GLAS America LLC (“GLAS America”) as collateral agent under the Company’s credit agreement dated January 16, 2019 (as amended, supplemented or otherwise…

Details

EU CBD in E-Liquids Guide 2019 – ResearchAndMarkets.com

October 17, 2019

DUBLIN–(BUSINESS WIRE)–The “CBD in E-Liquids: A Guide For The EU” report has been added to ResearchAndMarkets.com’s offering. CBD for vaping is not as straightforward as one might imagine, despite there being vaping product regulations in Europe with the existence of the Tobacco Products Directive (TPD). The convergence of vaping and CBD has caught some governments…

Details

FSD Pharma Announces Temporary Change in OTCQB Ticker Symbol to FSDDD

October 17, 2019

TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDD) (FRA: 0K9) (“FSD” or the “Company”) today announced that the Company’s Class B Shares are trading on the OTCQB under the ticker symbol FSDDD for 20 business days, effective as of October 16, 2019. On November 13, 2019, the OTCQB symbol will revert to FSDDF. The temporary…

Details

Inversago Pharma Strengthens its Board of Directors with the Appointment of Two Industry Experts

October 17, 2019

MONTREAL–(BUSINESS WIRE)–Today Inversago Pharma Inc., a preclinical-stage biotech company developing novel CB1 blockers for the treatment of targeted metabolic disorders, announced the appointment of two seasoned pharma executives in line with the Company’s aim to attract first-class industry leaders for their guidance and expertise. Inversago welcomes Dennis Kim, MD, MBA and Tara Nickerson, PhD, MBA…

Details

Kohl’s Launches Unprecedented Number of Brands Just in Time for Holiday

October 17, 2019

MENOMONEE FALLS, Wis.–(BUSINESS WIRE)–Kohl’s (NYSE: KSS) celebrates the launch of a significant number of new brands joining its product portfolio during the fall and holiday seasons, offering newness at every turn for Kohl’s customers. Shoppers will discover new brands across product categories including new brands to Kohl’s, exciting collaborations and new partnerships with existing Kohl’s…

Details

REPEAT/Halo Labs Announces Closing of Second Tranche For Completion Of Aggregate CAD $4 Million Private Placement

October 17, 2019

TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company“) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that, further to the Company’s press releases of October 7, 2019 and October 11, 2019, Halo has closed a second tranche of the previously announced non-brokered increased private placement of Halo common shares (the “Offering”) at a…

Details

cbdMD, Inc. Announces Closing of $5.0 Million 8.0% Series A Cumulative Convertible Preferred Stock Offering

October 16, 2019

CHARLOTTE, N.C.–(BUSINESS WIRE)–cbdMD, Inc. (NYSE American: YCBD), today announced the closing of its previously announced underwritten public offering of 500,000 shares of its 8.0% Series A Cumulative Convertible Preferred Stock at a purchase price of $10.00 per share for total gross proceeds of $5,000,000, before deducting underwriting discounts, commissions and other offering expenses payable by…

Details